TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
Pulmonary fibrosis (PF) is the pathological structure of incurable fibroproliferative lung diseases that are attributed to the repeated lung injury-caused failure of lung alveolar regeneration (LAR). Here, we report that repetitive lung damage results in a progressive accumulation of the transcripti...
Saved in:
Main Authors: | Xiaoxi Lv (Author), Shanshan Liu (Author), Chang Liu (Author), Yunxuan Li (Author), Tingting Zhang (Author), Jie Qi (Author), Ke Li (Author), Fang Hua (Author), Bing Cui (Author), Xiaowei Zhang (Author), Yuxin Liu (Author), Jiaojiao Yu (Author), Jinmei Yu (Author), Li Li (Author), Xia Li (Author), Zhigang Yao (Author), Bo Huang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target
by: Shanshan Liu, et al.
Published: (2021) -
The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration
by: Xiaoxi Lv, et al.
Published: (2022) -
Inhibition of TRIB3 Protects Against Neurotoxic Injury Induced by Kainic Acid in Rats
by: Jing Zhang, et al.
Published: (2019) -
Effect of TRIB1 Variant on Lipid Profile and Coronary Artery Disease: A Systematic Review and Meta-Analysis
by: Baozhu Wei, et al.
Published: (2023) -
Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications
by: Fazhong He, et al.
Published: (2018)